skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines letermovirQuestion & answer

letermovir · Medicine question

Does letermovir treat active CMV disease?

iatroX medicinesPublished 21 August 2026Reviewed 21 August 2026

The answer

Answer

No. These products are licensed for prevention, not treatment of established CMV disease. Breakthrough CMV requires prompt specialist assessment.

Sources for this answer

PREVYMIS 240 mg film-coated tabletsemc · SmPC Current selected SmPC · Version 14
PREVYMIS 240 mg concentrate for solution for infusionemc · SmPC Current selected SmPC · Version 9

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

More questions about letermovir

Can the tablets be crushed or chewed?Can tablets and infusion be switched?Why are CMV blood tests still needed?

The full medicine guide

letermovir

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the letermovir guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX